Results
|
21.
|
Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study. [electronic resource] by
- Hollander, Priscilla
- Liu, Jie
- Hill, Julie
- Johnson, Jeremy
- Jiang, Zhi Wei
- Golm, Gregory
- Huyck, Susan
- Terra, Steven G
- Mancuso, James P
- Engel, Samuel S
- Lauring, Brett
Publication details: Diabetes therapy : research, treatment and education of diabetes and related disorders Feb 2018
In:
Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 9
Availability: No items available.
|
|
22.
|
Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial. [electronic resource] by
- Arjona Ferreira, Juan C
- Corry, Dalila
- Mogensen, Carl E
- Sloan, Lance
- Xu, Lei
- Golm, Gregory T
- Gonzalez, Edward J
- Davies, Michael J
- Kaufman, Keith D
- Goldstein, Barry J
Producer: 20130523
In:
American journal of kidney diseases : the official journal of the National Kidney Foundation vol. 61
Availability: No items available.
|
|
23.
|
Randomized clinical trial of the safety and efficacy of sitagliptin and metformin co-administered to Chinese patients with type 2 diabetes mellitus. [electronic resource] by
- Ji, Linong
- Han, Ping
- Wang, Xiaoyue
- Liu, Jingdong
- Zheng, Shaoxiong
- Jou, Ying-Ming
- O'Neill, Edward A
- Golm, Gregory T
- Engel, Samuel S
- Kaufman, Keith D
- Shankar, R Ravi
Producer: 20170217
In:
Journal of diabetes investigation vol. 7
Availability: No items available.
|
|
24.
|
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trial. [electronic resource] by
- Home, Philip D
- Lam, Raymond L H
- Carofano, Wendy L
- Golm, Gregory T
- Eldor, Roy
- Crutchlow, Michael F
- Marcos, Michael C
- Rosenstock, Julio
- Hollander, Priscilla A
- Gallwitz, Baptist
Producer: 20190205
In:
Diabetes, obesity & metabolism vol. 20
Availability: No items available.
|
|
25.
|
Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo-controlled randomized study. [electronic resource] by
- Dagogo-Jack, Samuel
- Liu, Jie
- Eldor, Roy
- Amorin, Guillermo
- Johnson, Jeremy
- Hille, Darcy
- Liao, Yuqin
- Huyck, Susan
- Golm, Gregory
- Terra, Steven G
- Mancuso, James P
- Engel, Samuel S
- Lauring, Brett
Producer: 20181211
In:
Diabetes, obesity & metabolism vol. 20
Availability: No items available.
|
|
26.
|
Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. [electronic resource] by
- Barzilai, Nir
- Guo, Hua
- Mahoney, Erin M
- Caporossi, Suzanne
- Golm, Gregory T
- Langdon, Ronald B
- Williams-Herman, Debora
- Kaufman, Keith D
- Amatruda, John M
- Goldstein, Barry J
- Steinberg, Helmut
Producer: 20110728
In:
Current medical research and opinion vol. 27
Availability: No items available.
|
|
27.
|
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial. [electronic resource] by
- Pratley, Richard E
- Eldor, Roy
- Raji, Annaswamy
- Golm, Gregory
- Huyck, Susan B
- Qiu, Yanping
- Sunga, Sheila
- Johnson, Jeremy
- Terra, Steven G
- Mancuso, James P
- Engel, Samuel S
- Lauring, Brett
Producer: 20190114
In:
Diabetes, obesity & metabolism vol. 20
Availability: No items available.
|
|
28.
|
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trial. [electronic resource] by
- Hollander, Priscilla A
- Carofano, Wendy L
- Lam, Raymond L H
- Golm, Gregory T
- Eldor, Roy
- Crutchlow, Michael F
- Marcos, Michael C
- Rendell, Marc S
- Home, Philip D
- Gallwitz, Baptist
- Rosenstock, Julio
Producer: 20190205
In:
Diabetes, obesity & metabolism vol. 20
Availability: No items available.
|
|
29.
|
Double-blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase-4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT-I Study. [electronic resource] by
- Roussel, Ronan
- Duran-García, Santiago
- Zhang, Yilong
- Shah, Suneri
- Darmiento, Carolyn
- Shankar, R Ravi
- Golm, Gregory T
- Lam, Raymond L H
- O'Neill, Edward A
- Gantz, Ira
- Kaufman, Keith D
- Engel, Samuel S
Producer: 20200907
In:
Diabetes, obesity & metabolism vol. 21
Availability: No items available.
|
|
30.
|
Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV). [electronic resource] by
- Cannon, Christopher P
- McGuire, Darren K
- Pratley, Richard
- Dagogo-Jack, Sam
- Mancuso, James
- Huyck, Susan
- Charbonnel, Bernard
- Shih, Weichung J
- Gallo, Silvina
- Masiukiewicz, Urszula
- Golm, Gregory
- Cosentino, Francesco
- Lauring, Brett
- Terra, Steven G
Producer: 20190624
In:
American heart journal vol. 206
Availability: No items available.
|
|
31.
|
Efficacy and safety of sitagliptin added to ongoing metformin and rosiglitazone combination therapy in a randomized placebo-controlled 54-week trial in patients with type 2 diabetes. [electronic resource] by
- Dobs, Adrian S
- Goldstein, Barry J
- Aschner, Pablo
- Horton, Edward S
- Umpierrez, Guillermo E
- Duran, Lorraine
- Hill, Julie S
- Chen, Yu
- Golm, Gregory T
- Langdon, Ronald B
- Williams-Herman, Debora E
- Kaufman, Keith D
- Amatruda, John M
- Ferreira, Juan Camilo Arjona
Producer: 20130708
In:
Journal of diabetes vol. 5
Availability: No items available.
|